Duarte, Rui V, Houten, Rachel ORCID: 0000-0002-4315-7732, Nevitt, Sarah, Brookes, Morag, Bell, Jill, Earle, Jenny, Gulve, Ashish, Thomson, Simon, Baranidharan, Ganesan, North, Richard B et al (show 2 more authors)
(2022)
Screening trials of spinal cord stimulation for neuropathic pain in England-A budget impact analysis.
FRONTIERS IN PAIN RESEARCH, 3.
974904-.
PDF
Screening trials of spinal cord stimulation for neuropathic pain in England-A budget impact analysis.pdf - Published version Download (373kB) | Preview |
Abstract
Screening trials of spinal cord stimulation (SCS) prior to full implantation of a device are recommended by expert guidelines and international regulators. The current study sought to estimate the budget impact of a screening trial of SCS and the costs or savings of discontinuing the use of a screening trial. A budget impact analysis was performed considering a study population that reflects the size and characteristics of a patient population with neuropathic pain in England eligible for SCS. The perspective adopted was that of the NHS with a 5-year time horizon. The base case analysis indicate that a no screening trial strategy would result in cost-savings to the NHS England of £400,000-£500,000 per year. Sensitivity analyses were conducted to evaluate different scenarios. If ≥5% of the eligible neuropathic pain population received a SCS device, cost-savings would be >£2.5 million/year. In contrast, at the lowest assumed cost of a screening trial (£1,950/patient), a screening trial prior to SCS implantation would be cost-saving. The proportion of patients having an unsuccessful screening trial would have to be ≥14.4% for current practice of a screening trial to be cost-saving. The findings from this budget impact analysis support the results of a recent UK multicenter randomized controlled trial (TRIAL-STIM) of a policy for the discontinuation of compulsory SCS screening trials, namely that such a policy would result in considerable cost-savings to healthcare systems.
Item Type: | Article |
---|---|
Uncontrolled Keywords: | budget impact analysis, spinal cord stimulation, screening trials, neuropathic pain, cost savings |
Divisions: | Faculty of Health and Life Sciences Faculty of Health and Life Sciences > Institute of Population Health |
Depositing User: | Symplectic Admin |
Date Deposited: | 25 Jan 2023 14:40 |
Last Modified: | 27 Jun 2023 20:51 |
DOI: | 10.3389/fpain.2022.974904 |
Related URLs: | |
URI: | https://livrepository.liverpool.ac.uk/id/eprint/3167891 |